CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health ...

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual ...

Former Oklahoma Gov. David Boren, who became one of the nation’s youngest governors in the 1970s at age 33 and later helped shape national intelligence as a U.S.

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...